Company Filing History:
Years Active: 1996-2004
Title: The Innovative Contributions of Susan K. Keesee in Cancer Detection
Introduction: Susan K. Keesee, located in Harvard, MA, is an accomplished inventor known for her significant contributions to the field of cancer detection. With a remarkable portfolio of seven patents, Keesee has dedicated her efforts to developing innovative methods and compositions that aim to enhance the detection and treatment of various cancers, notably cervical and breast cancer.
Latest Patents: Among her latest innovations, Keesee’s patents include methods for the detection of cervical cancer, which provide a range of approaches for identifying and treating this disease in individuals. Her invention focuses on target cervical cancer-associated proteins that allow for rapid detection, ideally before metastasis occurs. This detection can be achieved by reacting a sample with a labeled binding moiety, such as a labeled antibody specifically designed to bind to these proteins. Additionally, her work includes the development of kits that facilitate the detection of cervical cancer and methods that utilize these proteins as targets for treatment and as indicators to monitor the efficacy of treatments.
Another significant invention is her work on materials and methods for detecting breast cancer. This innovation discloses proteins indicative of breast cancer, as well as methodologies that provide substantial improvements in cancer detection assays, particularly for breast cancer.
Career Highlights: Susan K. Keesee is currently associated with Matritech, Inc., a company that focuses on innovative technologies for cancer detection. Her works have not only enriched the company’s portfolio but have also enhanced the collective understanding and methodologies regarding cancer diagnostics. Her inventive contributions emphasize her commitment to advancing medical science and improving early detection mechanisms for life-threatening conditions.
Collaborations: Throughout her career, Keesee has collaborated with notable professionals, including Ying-Jye Wu and Robert A. Obar. These partnerships highlight the collaborative nature of scientific research, enabling the amalgamation of diverse expertise to drive innovation in cancer detection.
Conclusion: Susan K. Keesee remains a pivotal figure in the innovation landscape of cancer diagnostics. Her patents represent a significant stride towards more efficient and effective cancer detection methods, potentially improving patient outcomes. Through her ongoing work and collaborations, Keesee continues to inspire innovation and progress in the pursuit of better health solutions.